NCT06806202View on ClinicalTrials.gov

Warm Versus Conventional 2% Lignocaine for IANB Efficacy

PHASE2RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 15, 2024

Primary Completion Date

March 15, 2025

Study Completion Date

March 15, 2025

Conditions
Success of Inferior Alveolar Nerve BlockInferior Alveolar Nerve Block
Interventions
DRUG

conventional 2% lignocaine at room temperature

This study aims to compare the effectiveness of warm 2% lignocaine (lidocaine) versus conventional room temperature 2% lignocaine for achieving successful inferior alveolar nerve blocks (IANB) in mandibular permanent molars

DRUG

pre-warmed 2% lignocaine at 42°C

This study aims to compare the effectiveness of warm 2% lignocaine (lidocaine) versus conventional room temperature 2% lignocaine for achieving successful inferior alveolar nerve blocks (IANB) in mandibular permanent molars

Trial Locations (1)

46000

RECRUITING

Armed Forces Institute Of Dentistry, Rawalpindi

All Listed Sponsors
lead

Armed Forces Institute of Dentistry, Pakistan

OTHER